Daniela Stokmaier

442 total citations
7 papers, 291 citations indexed

About

Daniela Stokmaier is a scholar working on Pathology and Forensic Medicine, Neurology and Infectious Diseases. According to data from OpenAlex, Daniela Stokmaier has authored 7 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 1 paper in Infectious Diseases. Recurrent topics in Daniela Stokmaier's work include Multiple Sclerosis Research Studies (4 papers), Peripheral Neuropathies and Disorders (3 papers) and vaccines and immunoinformatics approaches (1 paper). Daniela Stokmaier is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Peripheral Neuropathies and Disorders (3 papers) and vaccines and immunoinformatics approaches (1 paper). Daniela Stokmaier collaborates with scholars based in Switzerland, United States and Canada. Daniela Stokmaier's co-authors include Anthony Traboulsee, Cathy Chognot, Kevin Winthrop, Marianna Manfrini, Amit Bar‐Or, Jonathan Calkwood, Edward Fox, Jeanette Wendt, Derrick Robertson and Ann Herman and has published in prestigious journals such as Neurology, Investigative Ophthalmology & Visual Science and Neurology Neuroimmunology & Neuroinflammation.

In The Last Decade

Daniela Stokmaier

7 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Stokmaier Switzerland 4 220 149 134 96 52 7 291
Jeanette Wendt United States 4 248 1.1× 139 0.9× 126 0.9× 93 1.0× 78 1.5× 5 326
Gustavo Luna United States 3 272 1.2× 112 0.8× 149 1.1× 91 0.9× 88 1.7× 4 363
Licínio Craveiro Switzerland 8 187 0.8× 49 0.3× 98 0.7× 72 0.8× 61 1.2× 27 258
Maya Zeineddine Lebanon 10 231 1.1× 32 0.2× 77 0.6× 49 0.5× 102 2.0× 30 282
Rosa Gershtein Israel 8 131 0.6× 28 0.2× 51 0.4× 107 1.1× 33 0.6× 10 321
Ruggero Caputo Italy 7 107 0.5× 72 0.5× 14 0.1× 31 0.3× 50 1.0× 10 228
J. Atta Germany 9 115 0.5× 49 0.3× 71 0.5× 5 0.1× 58 1.1× 18 255
Amalia Tejeda Velarde Spain 6 29 0.1× 63 0.4× 18 0.1× 95 1.0× 7 0.1× 24 168
J. Huang United States 4 121 0.6× 62 0.4× 30 0.2× 20 0.2× 158 3.0× 5 205
Tulip Tan Singapore 9 106 0.5× 17 0.1× 25 0.2× 56 0.6× 11 0.2× 15 275

Countries citing papers authored by Daniela Stokmaier

Since Specialization
Citations

This map shows the geographic impact of Daniela Stokmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Stokmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Stokmaier more than expected).

Fields of papers citing papers by Daniela Stokmaier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Stokmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Stokmaier. The network helps show where Daniela Stokmaier may publish in the future.

Co-authorship network of co-authors of Daniela Stokmaier

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Stokmaier. A scholar is included among the top collaborators of Daniela Stokmaier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Stokmaier. Daniela Stokmaier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Kleiter, Ingo, Anthony Traboulsee, Jacqueline Palace, et al.. (2022). Long-term Efficacy of Satralizumab in AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar. Neurology Neuroimmunology & Neuroinflammation. 10(1). 34 indexed citations
2.
Hašková, Zdenka, Benjamin Greenberg, Jeffrey L. Bennett, et al.. (2021). Efficacy and safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD): Results from open-label extension periods of SAkuraSky and SAkuraStar. Investigative Ophthalmology & Visual Science. 62(8). 3475–3475. 1 indexed citations
3.
Traboulsee, Anthony, Michael R. Yeaman, Brian G. Weinshenker, et al.. (2021). Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder and Concomitant Autoimmune Disease (4118). Neurology. 96(15_supplement). 1 indexed citations
4.
5.
Bar‐Or, Amit, Jonathan Calkwood, Cathy Chognot, et al.. (2020). Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis. Neurology. 95(14). e1999–e2008. 230 indexed citations
6.
7.
Stokmaier, Daniela, et al.. (2018). Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis (S36.002). Neurology. 90(15_supplement). 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeanette Wendt Breakdown of academic impact, for papers by Gustavo Luna Breakdown of academic impact, for papers by Licínio Craveiro Breakdown of academic impact, for papers by Maya Zeineddine Breakdown of academic impact, for papers by Rosa Gershtein Breakdown of academic impact, for papers by Ruggero Caputo Breakdown of academic impact, for papers by J. Atta Breakdown of academic impact, for papers by Amalia Tejeda Velarde Breakdown of academic impact, for papers by J. Huang Breakdown of academic impact, for papers by Tulip Tan
Rankless by CCL
2026